Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

124results about How to "Improve blood sugar levels" patented technology

Diabetes-specific enteral nutrition multi-polymerization agent

InactiveCN104286849AImprove oral glucose toleranceLower fasting blood sugar levelsFood preparationNutrientDiabetic complication
The invention provides a diabetes-specific enteral nutrition multi-polymerization agent. The diabetes-specific enteral nutrition multi-polymerization agent comprises the following energy by weight percentage: 50%-60% of carbohydrates, 10%-15% of proteins and 25%-35% of fat, wherein the energy supply ratio of monounsaturated fatty acids is 10-20%. The invention provides the nutrition multi-polymerization agent with balanced nutrients and low GI (glycemic index) value against the metabolic characteristics of diabetic patients, which can effectively correct metabolic disorders, reduce the islet beta-cell load and delay and reduce the occurrence and development of diabetic complications. The diabetes-specific enteral nutrition multi-polymerization agent provided by the invention is particularly suitable for the diabetic patients, patients with severe symptoms, traumas and surgical stress associated with high blood sugar, and people with decreased sugar tolerance.
Owner:上海励成营养产品科技股份有限公司

Prophylactic and therapeutic agent of diabetes mellitus

The invention provides a prophylactic and therapeutic agent of diabetes mellitus, including a combination of an inhibitor of renal glucose reabsorption and a hypoglycemic agent. In accordance with the invention, hyperglycemia after meals, between meals and during fasting can be ameliorated. More specifically, in accordance with the invention, a therapeutic effect of diabetes mellitus as never been obtained by the hypoglycemic agents of the related art can be achieved.
Owner:AJINOMOTO CO INC

Individual insulin treatment guide instrument for diabetics and application method thereof

InactiveCN101866387AImprove blood sugar target rateIncreased blood sugarSpecial data processing applicationsData informationInsulin treated diabetes
The invention relates to an individual insulin treatment guide instrument for diabetics and an application method thereof, wherein the guide instrument comprises a blood sugar data input module, a blood sugar data processing module, a blood sugar data base module, a treatment guide information output module and a display module. The method comprises the following steps: importing the treatment guide information of diabetes into the blood sugar data base module; inputting the blood sugar data information of patients into the blood sugar data input module; carrying out data fitting processing according to the blood sugar data information and the treatment guide information of the diabetes and generating a treatment guide scheme; carrying out computation processing on specific applied dosage according to the treatment scheme; and displaying the information of the treatment guide scheme. By adopting the individual insulin treatment guide instrument for the diabetics and the application method thereof, the intelligentized, normative and accurate judgement is realized and the reasonable treatment guide scheme is provided for the diabetics requiring insulin treatment. The guide instrument has simple and practical structure, convenient and rapid application process, stable and reliable working performance, relatively low cost and convenient popularization and application.
Owner:SHANGHAI YANGPU CENT HOSPITAL

Amylin activity assays

Novel methods for use in identifying or assaying compounds which can simulate the ability of amylin to cause hyperlactemia and hyperglycemia in in vivo biological models, or for use in evaluating the potency of compounds known or suspected to simulate these actions of amylin, which involve introducing test samples into in vivo test systems and determining the presence or amount of a rise in lactate, or determining the presence or amount of a rise in lactate and a rise in glucose, following test sample administration.
Owner:ASTRAZENECA PHARMA LP

Traditional Chinese medicine compound preparation for treating type II diabetes mellitus and preparation method of traditional Chinese medicine compound preparation

The invention relates to a traditional Chinese medicine compound preparation for treating type II diabetes mellitus. The traditional Chinese medicine compound preparation is prepared from the following traditional Chinese medicine raw materials in parts by weight: 5-45 parts of codonopsis pilosula, 5-45 parts of astragalus membranaceus, 5-45 parts of Chinese yam, 5-45 parts of rhizoma polygonati, 1-9 parts of coptis chinensis, 3-27 parts of radix scutellariae, 5-45 parts of radix puerariae and 5-45 parts of ramulus euonymi. The invention also relates to a preparation method of the traditional Chinese medicine compound preparation. The preparation method of the traditional Chinese medicine compound preparation comprises the following steps: weighing traditional Chinese medicine raw materials, adding water for decocting the raw materials, filtering, combining filtrate and concentrating the filtrate; subsequently centrifuging, extracting supernate, concentrating, and adding pharmaceutically acceptable auxiliary materials so as to prepare a conventional preparation form of the traditional Chinese medicine compound preparation with low cost by using a conventional traditional Chinese medicine preparation method. According to the traditional Chinese medicine compound preparation, the therapeutic principle and theory of treatment determination from the spleen are taken as the guidance; the traditional Chinese medicine compound preparation has the functions of reinforcing qi and nourishing yin, strengthening the spleen and clearing heat, activating blood and reducing sugar in the clinical prevention and treatment of the type II diabetes mellitus; meanwhile, the traditional Chinese medicine compound preparation is safe, effective and relatively small in taking amount.
Owner:SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV OF T C M

Propolis soft capsule and preparation method thereof

The invention discloses a propolis soft capsule and a preparation method thereof. The propolis soft capsule is prepared by adding an appropriate quantity of auxiliary materials to 100-200 grams of propolis and 300-400 grams of corn oil by weight to prepare 1000 capsule granules. The invention can regulate hyperglycemia, prevent and adjunctively treat diabetes and can also regulate hyperlipemia and reduce worries of obese patients.
Owner:杭州天厨蜜源保健品有限公司

Composition with effect of improving blood glucose level and preparation method thereof

The invention relates to a composition with an effect of improving the blood glucose level and a preparation method thereof. The composition is prepared from the following raw materials in parts by weight: 25-40 parts of chestnut shell extract, 10-20 parts of mulberry leaf extract and 3-5 parts of oat beta-glucan, and can be further added with the following components in parts by weight: 5-10 parts of bitter gourd powder, 1-2 parts of chromium containing yeast powder, 5-10 parts of bitter gourd extract, 10-20 parts of barley malt, 5-10 parts of haematococcus pluvialis powder, 3-5 parts of oatfibers, 5-10 parts of Chinese yam meal, 1-2 parts of chrysanthemum powder, 3-5 parts of buckwheat meal, 4-7 parts of polygonatum odoratum powder, 3-5 parts of kudzu vine root powder and 0.1-1 part ofvitamin B2. The composition is rich in nutrition and convenient to eat, can be used for effectively improving the blood glucose level, and has a certain health-protecting effect.
Owner:GUANGZHOU ZHENGGUANG BIOTECH CO LTD

Tablettized candies with effects of lowering blood sugar, lowering blood lipid, increasing immunity and resisting oxidization as well as preparation method and application thereof

The invention relates to the technical field of health-care food, and particularly relates to tablettized candies with effects of lowering blood sugar, lowering blood lipid, increasing immunity and resisting oxidization as well as a preparation method and application thereof. The tablettized candies are prepared from the following raw materials in percentage by weight: 15 to 40 percent of cyclocarya paliurus peel, root or leaf extracts, 10 to 40 percent of fermented cordyceps sinensis powder, 1 to 5 percent of selenium-rich vegetable protein, 5 to 20 percent of fructus lycll extracts, 5 to 20 percent of poria cocos extracts, 8 to 35 percent of filling agent, 0.1 to 6 percent of disintegrating agent, and 0.1 to 3 percent of lubricant. The raw materials are evenly mixed and tablettized to obtain the tablettized candies with the effects of lowering the blood sugar, lowering the blood lipid, increasing the immunity and resisting the oxidization. The tablettized candies provided by the invention have the effects of obviously lowering the blood sugar, lowering the blood lipid, increasing the immunity and resisting the oxidization, and can be applied to preparation of food or drugs for lowering the blood sugar, lowering the blood lipid, increasing the immunity and resisting the oxidization.
Owner:湖北思慧生物科技有限公司 +1

DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic Diseases

A composition and method of treatment of neuromuscular, neuromuscular degenerative, neurodegenerative, autoimmune, developmental, traumatic, hearing loss related, and/or metabolic diseases, including spinal muscular atrophy (SMA) syndrome (SMA1, SMA2, SMA3, and SMA4, also called Type I, II, III and IV), traumatic brain injury (TBI), concussion, keratoconjunctivitis sicca (Dry Eye Disease), glaucoma, Sjogren's syndrome, rheumatoid arthritis, post-LASIK surgery, anti-depressants use, Wolfram Syndrome, and Wolcott-Rallison syndrome. The composition is selected from the group consisting of 2,3-DNP, 2,4-DNP, 2,5-DNP, 2,6-DNP, 3,4-DNP, or 3,5-DNP, bipartite 2,3-dinitrophenol, 2,4-dinitrophenol, 2,5-dinitrophenol, 2,6-dinitrophenol, 3,4-dinitrophenol, or 3,5-dinitrophenol (2,3-DNP, 2,4-DNP, 2,5-DNP, 2,6-DNP, 3,4-DNP, or 3,5-DNP) prodrugs; Gemini prodrugs, bioprecursor molecules, and combinations thereof. A dose of the composition for treatment of neurodegenerative diseases may be from about 0.01 mg/kg of body weight to about 50 mg/kg of body weight of the patient in need of treatment. A dose of the composition for treatment of metabolic diseases may be from about 1 mg/70 kg of body weight to about 100 mg/70 kg of body weight of the patient in need of treatment, and a maximum dose per day is about 200 mg/70 kg of body weight of the patient in need of treatment.
Owner:MITOCHON PHARMA INC +1

Composition capable of lowering blood glucose as well as preparation and application of composition

The invention discloses a composition capable of lowering blood glucose as well as preparation and application of the composition. The composition capable of lowering the blood glucose is prepared from the following components in parts by weight: 50 to 350 parts of folium mori extract, 100 to 500 parts of bitter gourd extract, 75 to 250 parts of American ginseng root extract and 5 to 50 parts of chromium-enriched yeast. The invention further discloses food, medicine or health-care product containing the composition and a related preparation method. According to the composition capable of lowering the blood glucose or tablets capable of lowering the blood glucose, folium mori, bitter gourds, American ginseng root and the chromium-enriched yeast are matched according to a prescription and the use amount of each component is limited; the composition has a remarkable improvement effect on main clinical symptoms of diabetes mellitus.
Owner:上海紫石生物科技有限公司

Neutral vegetable protein drink and preparation method

The invention discloses a neutral vegetable protein drink and a preparation method. The neutral vegetable protein drink comprises, 40-50 parts of walnut protein isolates, 20-30 parts of peanut protein isolates, 6-10 parts of white sugar, 3-6 parts of honey, 1-3 parts of pectase, 1-3 parts of neutral protease, 2-4 parts of fructo-oligosaccharide, 2-4 parts of maltose, 1-3 parts of neutral vegetable protein drink stabilizers and 60-80 parts of purified water. The preparation method of the neutral vegetable protein drink comprises the steps of hydration, preheating, homogenizing, mixing, sterilization and canning and detection and warehousing. The neutral vegetable protein drink is simple in technology, high in producing efficiency and nutrient value, good in taste and worthy of popularization.
Owner:安徽扬子真爱你食品有限公司

Blood Sugar Level Measuring Apparatus, Blood Sugar Level Measured Result Display Method and Blood Sugar Level Measured Result Display Control Program

A measured result reflecting a body condition of a user when measuring a blood sugar level can be displayed, and convenience of management of the blood sugar level of the user is improved. A blood sugar level measuring apparatus includes: a measuring unit to measure a blood sugar level of a user; a recording unit to record measurement data thereof; and a display unit capable of displaying a measured result on a display, wherein the improvement comprises: a condition flag setting unit to record, on the recording unit, a condition flag related to a body condition of the user when measuring the blood sugar level; and a display control unit to display the measured result recorded on the recording unit on the display on the basis of the condition flag set by the condition flag setting unit.
Owner:ARKRAY INC

Compositions, methods, and kits relating to resistin

InactiveUS20070104708A1Improvement of blood sugar levelIncreasing insulin-stimulated glucose uptakePeptide/protein ingredientsTissue cultureThiazolidinedioneResistin Gene
The invention relates to novel nucleic acids encoding a mammalian resistin gene, and proteins encoded thereby, whose expression is suppressed by the antidiabetic compounds thiazolidinediones. The invention further relates to methods of treating and detecting type 2 diabetes and Syndrome X comprising modulating or detecting resistin expression and / or production and activity of resistin polypeptide.
Owner:THE TRUSTEES OF THE UNIV OF PENNSYLVANIA

Method for preparing high maltose oligosaccharide

The invention provides a method for preparing high maltose oligosaccharide. The method includes the following steps of a, saccharifying, wherein after starch is liquefied, a sugar solution is saccharified through the combined effect of maltose trisaccharidase, barley beta-amylase and pullulanase to generate a product with the malt sugar content of about 40% and the maltotriose content of about 40%; b, chromatography separating and purifying, wherein the saccharified and concentrated sugar solution is purified with the chromatographic separation technology, and the mass fraction of feeding ranges from 55% to 60%; under the condition of the running temperature of 60 DEG C of a system, the malt sugar, the maltotriose and glucose are separated, and a feed solution with the component (the maltotriose and the malt sugar) content of 92% or above is obtained; c, refining, wherein the obtained high maltose oligosaccharide solution is subjected to activated carbon decoloring filtering, ion exchange desalting and vacuum concentrating, and the high maltose oligosaccharide product is obtained. The prepared high maltose oligosaccharide has the advantages of being high in purity, excellent in hygroscopicity and moisturizing performance, low in sweetness, good in heat resistance and acid resistance and the like.
Owner:SHANDONG BAILONG CHUANGYUAN BIO TECH

Coarse cereal grain bars and preparation method thereof

The invention discloses coarse cereal grain bars and a preparation method thereof, and relates to the technical field of process of coarse cereal grain. The coarse cereal grain bars are prepared from, by weight, 70-100 parts of grain, 50-80 parts of auxiliary materials such as nuts and dried fruits and 80-120 parts of a syrup adhesive, and wherein the ratio of the total weight parts of the grain and the auxiliary nut and dried fruit materials to the weight parts of the syrup adhesive is 6:4; the grain raw material involved in a formula of the coarse cereal grain bars has a low glycemic index (GI) value, which is beneficial for improving the blood glucose level of a patient needing blood glucose level reduction through diets, inulin contained in syrup is taken as fructo-oligosaccharide, and the coarse cereal grain bars have advantages of adjusting intestinal flora and the like and are suitable for being eaten by diabetics; the auxiliary materials mainly contain the nuts, the coarse cereal grain bars are crisp in taste, and then through baking, the raw materials present a specific fragrance through the Maillard reaction.
Owner:青海省轻工业研究所有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products